Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „raloxifene“
Suchtreffer
Begriffe & Kennungen
Raloxifene Teva · 4.8 · Another adverse reaction observed was leg cramps (5.5 % for raloxifene, 1.9 % for placebo in the prevention po
Eintrag öffnenRaloxifene Teva · 4.8 · Blood and lymphatic system disorders Uncommon: Thrombocytopeniaa Nervous system disorders Common: Headache, in
Eintrag öffnenRaloxifene Teva · 4.8 · Flu syndrome was reported by 16.2 % of raloxifene treated patients and 14.0 % of placebo treated patients.
Eintrag öffnenRaloxifene Teva · 4.8 · In a study (RUTH) of postmenopausal women with documented coronary heart disease or at increased risk for coro
Eintrag öffnenRaloxifene Teva · 4.8 · In a study of 10,101 postmenopausal women with documented coronary heart disease or at increased risk for coro
Eintrag öffnenRaloxifene Teva · 4.8 · In the RUTH study, peripheral oedema occurred in 14.1 % of the raloxifene-treated patients and 11.7 % of the p
Eintrag öffnenRaloxifene Teva · 4.8 · In the RUTH study, raloxifene did not affect the incidence of stroke, compared to placebo. However, there was
Eintrag öffnenRaloxifene Teva · 4.8 · In the RUTH study, venous thromboembolic events occurred at a frequency of approximately 2.0 % or 3.88 cases p
Eintrag öffnenRaloxifene Teva · 4.8 · In the prevention population discontinuations of therapy due to any adverse reaction occurred in 10.7 % of 581
Eintrag öffnenRaloxifene Teva · 4.8 · One further change was seen which was not statistically significant (p > 0.05), but which did show a significa
Eintrag öffnenRaloxifene Teva · 4.8 · Raloxifene (n = 317) was compared with continuous combined (n = 110) hormone replacement therapy (HRT) or cycl
Eintrag öffnenRaloxifene Teva · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenRaloxifene Teva · 4.8 · The following convention has been used for the classification of the adverse reactions: very common (≥ 1/10),
Eintrag öffnenRaloxifene Teva · 4.8 · The frequencies for postmarketing reports were calculated from placebo-controlled clinical trials (comprising
Eintrag öffnenRaloxifene Teva · 4.8 · a. Summary of the safety profile The clinically most important adverse reactions reported in postmenopausal wo
Eintrag öffnenRaloxifene Teva · 4.8 · b. Tabulated summary of adverse reactions The table below gives the adverse reactions and frequencies observed
Eintrag öffnenraloxifene
Eintrag öffnenraloxifene hydrochloride
Eintrag öffnenraloxifene hydrochloride
Eintrag öffnenraloxifene hydrochloride
Eintrag öffnen